Alercell, Inc.
PrivateLast Round
Seed
Oct 19, 2026
Total Funding Raised
$35,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Alercell, Inc. operates in Healthcare & Life Sciences and is based in Bozeman, Montana. Its latest recorded funding round was a Seed round in October 2026.
Alercell, Inc. is a precision oncology biotechnology company that develops AI-powered epigenetic diagnostic platforms for the early detection of leukemia and other cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alercell, Inc. Comparables
Compare Alercell, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| METHYS Dx | 83% | |
| Singlera Genomics Inc. | 80% | |
| Adela | 78% |
For institutional investors. Book with your work email.
Alercell, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 19, 2026 | ||||
| Series A | Mar 23, 2026 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 19, 2026
$35K raised in early funding.
- Mar 23, 2026
Completed a Series A funding round.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresOct 27, 2026
Alercell appoints James "Jim" A. Stipcich as Vice President, Business Development & Strategic Partnerships to lead partnership development and support its planned Montana pilot program in Montana on Oct 27th '26.
- hiresOct 27, 2026
Alercell appoints James "Jim" A. Stipcich as Vice President of Business Development and Strategic Partnerships to lead regional partnership development, including clinical site agreements and research collaborations supporting its planned Montana pilot program.
For institutional investors. Book with your work email.
Alercell, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Alercell, Inc.'s valuation, stock price, and market status.
Is Alercell, Inc. a public or private company?
Alercell, Inc. is a private company.
What is the current stock price of Alercell, Inc.?
Alercell, Inc. is a private company, so its shares have no public market price. Caplight tracks Alercell, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Alercell, Inc. worth (valuation)?
Valuation information for Alercell, Inc. is not publicly available.
Can I buy Alercell, Inc. stock?
Alercell, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Alercell, Inc.'s last funding round?
Alercell, Inc.'s most recent funding round was Seed on October 19, 2026.
Who are the main investors in Alercell, Inc.?
Investor information for Alercell, Inc. is not publicly disclosed.
Will Alercell, Inc. IPO soon?
No public IPO plans have been announced for Alercell, Inc..
How can I track Alercell, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Alercell, Inc.'s shares on secondary markets.